EPISODE · Aug 28, 2025 · 11 MIN
A Catholic Perspective on Embryo Genetic Testing Technology (Trending with Timmerie)
from The Best of the Week · host Relevant Radio
In this episode of Trending with Timmerie, guest host Brooke Taylor takes a Catholic look at the rise of embryo genetic testing and why it clashes with Church teaching on the dignity of life. The focus is on Orchid, a Silicon Valley startup offering parents the ability to screen embryos for genetic traits before conception. While the company markets this as “protecting children,” Brooke exposes how it reduces human life to a product; they are discarding embryos judged less “fit” and promoting a modern form of eugenics. It's truly heartbreaking to learn about this. You'll hear part of Ross Douthat’s New York Times interview with Orchid’s founder, Noor Siddiqui, while Brooke mentions the moral dangers of treating embryos as disposable. Siddiqui argues parents should optimize their child’s genome like they would a career or diet. But as Brooke says, this logic denies the truth that every human life is created in God’s image. She cites Cardinal Sarah’s warning about a “dictatorship of perfection” and the Vatican’s instruction on bioethics, which condemn embryo selection as a serious violation of human dignity. Brooke also shares her personal story of infertility, miscarriage, adoption, and parenting a special-needs child. Her witness reveals how Catholic teaching offers a radical “yes” to life, even when suffering is involved. She asks you to pray for those tempted by these evil technologies. We must embrace the call to protect life at its most vulnerable stage and resist cultural pressures to play God with creation. The best way to listen to the Best of the Week is on our #1 Free Catholic App. It’s free and always will be! To get and share the Relevant Radio app, check it out here.
NOW PLAYING
A Catholic Perspective on Embryo Genetic Testing Technology (Trending with Timmerie)
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m